Aleonar, Renelyn B.
HRN: 24-40-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2024
CEFUROXIME 1.5GM (VIAL)
06/08/2024
06/09/2024
IV
1.5grams
Q8hrs
S/P Repeat CS With BTL
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes